NewsRoom Articles - Page 819 of 1443

TuesdayJun 04, 2019 2:40 pm

IMAC Holdings Inc. (IMAC) Starts Presentation at 9th Annual LD Micro Invitational

IMAC Holdings (NASDAQ: IMAC) combines life science advancements with traditional medical care for movement-restricting diseases and conditions. It owns or manages outpatient clinics that provide regenerative, orthopedic and minimally invasive procedures and therapies. It has partnered with several active and former professional athletes, including brand ambassadors Ozzie Smith, David Price, Tony Delk and Mike Ditka. IMAC’s outpatient medical clinics emphasize its focus around treating sports and orthopedic injuries without surgery or opioids. For more information, visit the company's website at www.imacregeneration.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers,…

TuesdayJun 04, 2019 2:40 pm

Asia Pacific Wire & Cable Corp. (APWC) Starts Presentation at 9th Annual LD Micro Invitational

Asia Pacific Wire & Cable (NASDAQ: APWC) is principally engaged in the manufacture and distribution of telecommunications (copper and fiber optic) and power cable and enameled wire products in the Asia Pacific region, primarily in Thailand, China, Singapore and Australia. The company manufactures and distributes its own wire and cable products and also distributes wire and cable products manufactured by its principal shareholder, Pacific Electric Wire & Cable Company, a Taiwanese company. The company also provides project engineering services in the supply, delivery and installation of power cables to certain of its customers. For more information, visit the company's website…

TuesdayJun 04, 2019 2:40 pm

Atossa Genetics (ATOS) Starts Presentation at 9th Annual LD Micro Invitational

Atossa Genetics (NASDAQ: ATOS) is a clinical-stage biopharmaceutical company developing novel, proprietary therapeutics and delivery methods for breast cancer and other breast conditions. Atossa is developing “endoxifen” and a new way to deliver therapies, such as “CAR-T” cells, through microcatheters directly to the site of breast cancer. The company believes its innovative therapies and delivery methods can transform breast cancer treatment– with the goals of preventing breast cancer from developing in the first place, to increasing the odds of surviving for those who do develop this deadly disease. For more information, visit the company's website at www.atossagenetics.com. About NetworkNewsWire NetworkNewsWire…

TuesdayJun 04, 2019 2:40 pm

Sigma Labs Inc. (SGLB) Starts Presentation at 9th Annual LD Micro Invitational

Sigma Labs (NASDAQ: SGLB) is a software company that specializes in the development and commercialization of real-time computer aided inspection (CAI) solutions known as PrintRite3D for 3D advanced manufacturing technologies. Sigma’s products and services are engineered, manufactured, and qualified for use in highly demanding production environments for the aerospace & defense industries. Sigma’s innovative approach to quality control/assurance is a proactive, comprehensive and process-focused methodology that allows prediction with adequate confidence of product conformance to defined acceptance requirements. For more information, visit the company's website at www.sigmalabsinc.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to…

TuesdayJun 04, 2019 2:20 pm

Social Reality Inc. (SRAX) Starts Presentation at 9th Annual LD Micro Invitational

Social Reality (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX's technology delivers the tools to unlock data to reveal brands core consumers and their characteristics across marketing channels. Through its blockchain identification graph technology platform, BIGtoken, SRAX has developed a consumer-managed data marketplace where people can own, verify and sell access to their data thereby providing everyone in the Internet ecosystem choice, transparency, and compensation. SRAX's technology and tools deliver a digital competitive advantage for brands in the CPG, automotive, investor and lifestyle verticals by integrating all aspects of the advertising experience into one platform.…

TuesdayJun 04, 2019 2:20 pm

Arcimoto Inc. (FUV) Starts Presentation at 9th Annual LD Micro Invitational

Arcimoto (NASDAQ: FUV) is devising new technologies and patterns of mobility that together raise the bar for environmental efficiency, footprint and affordability. Arcimoto is the maker of the Fun Utility Vehicle® (FUV) — an affordable, joyful, pure electric vehicle for everyday drivers and fleets. Available for pre-order today, Arcimoto’s Fun Utility Vehicle is one of the lightest, most affordable, and most appropriate electric vehicles suitable for the daily driver. For more information, visit the company's website at www.arcimoto.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate…

TuesdayJun 04, 2019 2:20 pm

Standard Lithium Ltd. (TSXV: SLL) (STLHF) (FRA: S5L) Starts Presentation at 9th Annual LD Micro Invitational

Standard Lithium (TSXV: SLL) (OTCQX: STLHF) (FRA: S5L) is engaged in the testing and proving of the commercial viability of lithium extraction from over 150,000 acres of permitted brine operations in southern Arkansas utilizing the company’s proprietary selective extraction technology. The company is also pursuing the resource development of over 30,000 acres of separate brine leases located in southwestern Arkansas and approximately 45,000 acres of mineral leases located in the Mojave Desert in San Bernardino County, California. For more information, visit the company's website at www.standardlithium.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our…

TuesdayJun 04, 2019 2:20 pm

Tiziana Life Sciences (TLSA) Starts Presentation at 9th Annual LD Micro Invitational

Tiziana Life Sciences (NASDAQ: TLSA) is a clinical-stage company developing targeted therapeutics to transform treatment of liver diseases, inflammatory diseases, and cancer. Tiziana’s two lead drug candidates, Foralumab and Milciclib, uniquely target the root cause of diseases with large unmet needs in multibillion-dollar markets. Through previous Phase II trials, both drug candidates have been de-risked by demonstration of both safety and efficacy in humans. Foralumab is the world’s first and only fully human anti-CD3 monoclonal antibody. This is a substantial advantage over similar antibody drugs which are sourced from mice and therefore cause unwanted immune responses in humans. For more…

TuesdayJun 04, 2019 2:20 pm

Cannabics Pharmaceuticals Inc. (CNBX) Starts Presentation at 9th Annual LD Micro Invitational

Cannabics Pharmaceuticals (OTC: CNBX) is developing a platform which leverages novel drug-screening tools and artificial intelligence to create cannabinoid-based therapies for cancer that are more precise to a patient's profile. By developing tools to assess effectiveness on a personalized basis, Cannabics is helping to move cannabinoids into the future of cancer therapy. The company's R&D is based in Israel, where it is licensed by the Ministry of Health to conduct scientific and clinical research on cannabinoid formulations and Cancer. For more information, visit the company’s website at www.cannabics.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access…

TuesdayJun 04, 2019 2:00 pm

Adamis Pharmaceuticals (ADMP) Starts Presentation at 9th Annual LD Micro Invitational

Adamis Pharmaceuticals (NASDAQ: ADMP) is a specialty biopharmaceutical company primarily focused on developing and commercializing products in various therapeutic areas, including respiratory disease and allergy. The company’s SYMJEPITM (epinephrine) Injection 0.3mg and SYMJEPITM (epinephrine) Injection 0.15mg products were approved by the FDA for use in the emergency treatment of acute allergic reactions, including anaphylaxis. Adamis is developing additional products, including a naloxone injection product candidate for the treatment of opioid overdose, a sublingual tadalafil product candidate for the treatment of erectile dysfunction, and a metered dose inhaler and dry powder inhaler product candidates for the treatment of asthma and COPD.…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

IMAC Holdings Inc. (IMAC) Starts Presentation at 9th Annual LD Micro Invitational

Asia Pacific Wire & Cable Corp. (APWC) Starts Presentation at 9th Annual LD Micro Invitational

Atossa Genetics (ATOS) Starts Presentation at 9th Annual LD Micro Invitational

Sigma Labs Inc. (SGLB) Starts Presentation at 9th Annual LD Micro Invitational

Social Reality Inc. (SRAX) Starts Presentation at 9th Annual LD Micro Invitational

Arcimoto Inc. (FUV) Starts Presentation at 9th Annual LD Micro Invitational

Standard Lithium Ltd. (TSXV: SLL) (STLHF) (FRA: S5L) Starts Presentation at 9th Annual LD Micro Invitational

Tiziana Life Sciences (TLSA) Starts Presentation at 9th Annual LD Micro Invitational

Cannabics Pharmaceuticals Inc. (CNBX) Starts Presentation at 9th Annual LD Micro Invitational

Adamis Pharmaceuticals (ADMP) Starts Presentation at 9th Annual LD Micro Invitational

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search